Skip to main content

Table 2 Inhaled pharmacological wash-out

From: A prospective study of salvational intervention with ICS/LABA for reducing chronic obstructive pulmonary disease exacerbation under severe air pollution (SIRCAP) in Beijing: protocol of a multi-center randomized controlled trial

Inhaled medication used before wash-out

Inhaled medication used during wash-out

Duration of wash-out

Tiotropium (18μg once q.d)

Maintain the original regimen

No washout, go directly into randomization

Budesonide/formoterol (160μg/4.5μg once or twice b.i.d)

Tiotropium (18μg once q.d) + budesonide/formoterol (160μg/4.5μg once or twice b.i.d)

No use of inhaled medication

Tiotropium (18μg once q.d)

Four weeks

Anticholinergic agents except tiotropium

Inhaled corticosteroids only

Tiotropium (18μg once q.d) + budesonide/formoterol (160μg/4.5μg once or twice b.i.d)

Inhaled β2-agonist only

ICS/LABA except budesonide/formoterol

LAMA+ICS/LABA except Tiotropium + budesonide/formoterol